中国普外基础与临床杂志

中国普外基础与临床杂志

胆囊癌的规范化手术治疗

查看全文

引用本文: 李斌, 姜小清. 胆囊癌的规范化手术治疗. 中国普外基础与临床杂志, 2019, 26(3): 265-269. doi: 10.7507/1007-9424.201902073 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2009: 211-217.
2. American Cancer Society. Cancer Facts and Figures 2013. Atlanta, GA: American Cancer Society, 2013.
3. Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Ame-rindians, and Maoris. Gastroenterology, 1998, 115(4): 937-946.
4. Sampliner RE, Bennett PH, Comess LJ, et al. Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med, 1970, 283(25): 1358-1364.
5. Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst, 1997, 89(15): 1132-1138.
6. Everhart JE, Yeh F, Lee ET, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology, 2002, 35(6): 1507-1512.
7. Yamauchi S, Koga A, Matsumoto S, et al. Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol, 1987, 82(1): 20-24.
8. Chijiiwa K, Kimura H, Tanaka M. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Int Surg, 1995, 80(1): 61-64.
9. Bai Y, Liu ZS, Xiong JP, et al. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol, 2018, 24(45): 5167-5178.
10. Kanthan R, Senger JL, Ahmed S, et al. Gallbladder Cancer in the 21st Century. J Oncol, 2015, 2015: 967472.
11. Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol, 2015, 21(43): 12211-12217.
12. Brierley JD, Mary K, Gospodarowicz CW. UNION for inter-national cancer control (UICC). TNM classification of malignant tumours (Eighth Edition). John Wiley & Sons, Ltd. 2017: 85-86.
13. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol, 2014, 6: 99-109.
14. Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg, 2015, 261(4): 733-739.
15. Lee H, Choi DW, Park JY, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol, 2015, 22(8): 2779-2786.
16. Park TJ, Ahn KS, Kim YH, et al. The optimal surgical resection approach for T2 gallbladder carcinoma: evaluating the role of surgical extent according to the tumor location. Ann Surg Treat Res, 2018, 94(3): 135-141.
17. Isambert M, Leux C, Métairie S, et al. Incidentally discovered gallbladder cancer: When, why and which reoperation? J ViscSurg, 2011, 148(2): e77-e84.
18. 于勇, 姜小清. 胆囊癌的外科分期治疗. 中华肝脏外科手术学电子杂志, 2012, 1(3): 151-156.
19. 邱应和, 刘辰, 易滨, 等. 181 例进展期胆囊癌外科治疗的预后分析. 中华肝胆外科杂志, 2010, 16(9): 655-658.
20. Lee SE, Kim SW, Han HS, et al. Surgical strategy for T2 gallbladder cancer: nationwide multicenter survey in Korea. J Korean Med Sci, 2018, 33(28): e186.
21. Dasari BVM, Ionescu MI, Pawlik TM, et al. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol, 2018, 118(3): 477-485.
22. Feng FL, Liu C, Li B, et al. Role of radical resection in patients with gallbladder carcinoma and jaundice. Chin Med J, 2012, 125(5): 752-756.
23. Ito M, Mishima Y, Sato T. An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat, 1991, 13(2): 89-104.
24. Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3rd English edition. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.
25. Creasy JM, Goldman DA, Dudeja V, et al. Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg, 2017, 224(5): 906-916.
26. Alzahrani NA, Valle SJ, Fisher OM, et al. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience. J Surg Oncol, 2019, 119(3): 336-346.
27. Liu Y, Yonemura Y, Levine EA, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal metastases from a small bowel adenocarcinoma: multi-institutional experience. Ann Surg Oncol, 2018, 25(5): 1184-1192.
28. Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol, 2015, 22(5): 1686-1693.
29. Ihemelandu C, Bijelic L, Sugarbaker PH. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. Ann Surg Oncol, 2015, 22(5): 1680-1685.
30. Sommariva A, Tonello M, Cona C, et al. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. Anticancer Res, 2018, 38(9): 5521-5524.
31. Randle RW, Levine EA, Clark CJ, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review. Am Surg, 2014, 80(7): 710-713.
32. Amblard I, Mercier F, Bartlett DL, et al. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol, 2018, 44(9): 1378-1383.
33. Abramson MA, Pandharipande P, Ruan D, et al. Radical resection for T1b gallbladder cancer: a decision analysis. HPB, 2009, 11: 656-663.
34. Hari DM, Howard JH, Leung AM, et al. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB, 2013, 15: 40-48.
35. 姜小清, 邱应和. 意外胆囊癌的诊断与治疗. 中华消化外科杂志, 2011, 10(2): 91-92.
36. 中国抗癌协会. 胆囊癌规范化诊治专家共识(2016). 中华肝胆外科杂志, 2016, 22(11): 721-728.
37. Benson AB 3rd, D'Angelica MI, Abrams TA, et al. NCCN clinical practice guidelines in oncology: Hepatobiliary cancers, version 2. J Natl Compr Canc Netw, 2014, 12(8): 1152-1182.
38. Kim HS, Park JW, Kim H, et al. Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study. J Hepatobiliary Pancreat Sci, 2018, 25(12): 533-543.
39. Vo E, Curley SA, Chai CY, et al. National failure of surgical staging for T1b gallbladder cancer. Ann Surg Oncol, 2019, 26(2): 604-610.
40. Švajdler P, Daum O, Dubová M, et al. Frozen section examination of pancreas, gallbladder, extrahepatic biliary tree, liver, and gastrointestinal tract. Cesk Patol, 2018, 54(2): 63-71.